SIRT3 and pancreatic neoplasm: SIRT3 has been identified as the main deacetylase of GOT2, and its deacetylation may not affect the enzyme activity of GOT2 itself but impairs the GOT2-MDH2 association, which negatively regulates malate-aspartate shuttle and impairs pancreatic cancer cell proliferation.